NEW YORK, April 24, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (IMNP) (“Immune” or the “Company”), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer, today announced a major corporate restructuring with the objective of prioritizing and segregating its research and development efforts on a focused set…
Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here. Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced a major corporate restructuring with the objective of prioritizing and segregating its research and development efforts on a focused set of products in inflammatory disease and dermatology and strengthening its…
BorgWarner Inc.BWA is set to release its first-quarter 2017 results before the market opens on Apr 27. Last quarter, the company posted a positive earnings surprise of 1.19%. It has delivered a positive surprise in each of the trailing four quarters, with an average of 1.55%. Let’s see how things have shaped up for the…
Shares of Immune Pharmaceuticals Inc. IMNP, -5.36% slid 9% in premarket trade Monday, after the company unveiled a restructuring and said it has received notice from the Nasdaq that it is not…
A potential spin-off of Cytovia into a stand-alone company pursuing an independent path from Immune would provide several advantages: Allows current Immune investors to benefit from two distinct investment opportunities through proportional receipt of shares in Cytovia; Enables Cytovia to target new investors attracted to its specific oncology business profile and pursue distinct capital structures…
CFO V Ramakrishnan says existing industry verticals will remain Mumbai, April 19: As growth slows in traditional business units, Indias largest software exporter TCS has begun the process of restructuring to focus better on digital technologies. TCS, which crossed $3 billion in digital revenues in fiscal 2017, will be focussing on the three core areas…
By Jof EnriquezFollow me on Twitter @jofenriq Johnson & Johnson (J&J) says it is making good progress with ongoing restructuring of its medical device business, but the company still is considering various options for its diabetes unit, including potential partnerships or divestitures. The world’ largest healthcare products manufacturer reported that global medical device sales grew…
New, easy to understand resources to help people in debt TORONTO , April 19, 2017 /CNW/ – Bankruptcy Canada has released a new range of tools, information and resources for Canadian debtors trapped in debt. Our Licensed Insolvency Trustee has produced valuable content to answer questions about how to get out of debt for people…
Burberry’s shares tumbled in early trade despite the fashion giant reporting an exceptional performance in the UK that helped its sales rise 3pc. The FTSE 100 stock dropped 5pc on opening in London after its performance for the six months to March 31 disappointed analyst expectations. A strong growth in sales of leather goods was a key…
The troubled online clothing retailer SurfStitch has sold action and extreme sport video business Garage Entertainment to the Madman Media Group for a loss. SurfStitch in 2015 paid $15 million in cash and shares for Garage and its assets including the acclaimed Australian documentary Bra Boys. The exact price paid by Madman wasnt revealed but…